Chapter 9. Emerging Risk Factors and Biomarkers of Cardiovascular Disease

  1. Peter P. Toth M.D., PH.D. Director of Preventive Cardiology Chief of Medicine Clinical Associate Professor1,2,3,4 and
  2. Kevin C. Maki PH.D. President Chief Science Officer5

Published Online: 1 OCT 2008

DOI: 10.1002/9780470696873.ch9

Practical Lipid Management: Concepts and Controversies

Practical Lipid Management: Concepts and Controversies

How to Cite

Toth, P. P. and Maki, K. C. (2008) Emerging Risk Factors and Biomarkers of Cardiovascular Disease , in Practical Lipid Management: Concepts and Controversies, John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470696873.ch9

Author Information

  1. 1

    Sterling Rock Falls Clinic, Ltd., USA

  2. 2

    CGH Medical Center Sterling, Illinois, USA

  3. 3

    Departments of Family and Community Medicine, University of Illinois College of Medicine Peoria, Illinois, USA

  4. 4

    Southern Illinois University School of Medicine, Springfield, Illinois, USA

  5. 5

    Provident Clinical Research & Consulting, Inc., Glen Ellyn, Illinois and Bloomington, Indiana, USA

Publication History

  1. Published Online: 1 OCT 2008
  2. Published Print: 17 OCT 2008

ISBN Information

Print ISBN: 9780470056905

Online ISBN: 9780470696873

SEARCH

Keywords:

  • cardiovascular disease (CVD);
  • C-reactive protein (hsCRP);
  • cardiovascular disease risk biomarker;
  • emerging risk factors;
  • hsCRP- ultrasensitive assay measuring hsCRP;
  • CVD events and hsCRP biomarker;
  • myeloperoxidase - atherosclerosis potentiator;
  • hyperhomocysteinemia and hypercoagulability

Summary

This chapter contains sections titled:

  • Role of Inflammation in the Pathogenesis of Atherosclerosis

  • Biomarkers of Cardiovascular Disease